View Single Post
Old 05-08-2006, 03:47 AM   #8
saleboat
Senior Member
 
saleboat's Avatar
 
Join Date: Sep 2005
Location: NYC
Posts: 250
Hi SaraD--

I'm glad you posted. Wondering if you've reviewed the study from Finland and the study recently posted here on Stage III women who received Herceptin neoadjuvent and did well without having Herceptin for a full year. I know these are small studies and shouldn't be taken as gospel. Wondering how they're interpreted by someone like yourself who actually has the training to make sense of them.

Thanks for any knowledge you can share with us.

Jen
__________________
dx 4/05 @ 34 y.o.
Stage IIIC, ER+ (90%)/PR+ (95%)/HER2+ (IHC 3+)
lumpectomy-- 2.5 cm 15+/37 nodes
(IVF in between surgery and chemo)
tx dd A/C, followed by dd Taxol & Herceptin
30 rads (or was it 35?)
Finished Herceptin on 7/24/06
Tamox
livingcured.blogspot.com

"Keep your face to the sunshine and you cannot see the shadow." -- Helen Keller
saleboat is offline   Reply With Quote